Canada markets closed

Valneva SE (VLA.VI)

Vienna - Vienna Delayed Price. Currency in EUR
Add to watchlist
6.36-0.16 (-2.42%)
At close: 05:32PM CET
Full screen
Previous Close6.52
Bid5.65 x 50000
Ask7.07 x 81200
Day's Range6.35 - 6.56
52 Week Range2.06 - 6.56
Avg. Volume14,123
Market Cap572.949M
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)-0.71
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks

    Valneva (VALN) Up on Antibody Persistence Data on Chikungunya Jab

    Valneva (VALN) posts encouraging 12-month antibody persistence data for its single-shot chikungunya vaccine candidate, VLA1553. Shares rise.

  • GlobeNewswire

    Valneva Hosts Investor Day in New York City

    Live event and webcast TODAY at 10 AM – 12 PM ET Saint-Herblain (France), December 06, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, is hosting an in-person investor day today in New York City to discuss the Company’s current vaccine pipeline, commercial products, and future directions. Valneva’s Chief Executive Officer Thomas Lingelbach, Chief Financial Officer Peter Bühler, and other members of the Company’s senior leadership team will highlight Valneva’s

  • GlobeNewswire

    VALNEVA - Declaration of shares and voting rights: November 30, 2022

    VALNEVA Declaration of shares and voting rightsNovember 30, 2022 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment A Declaration date: December 5, 2022 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the changeDate on which this chan